Dermatofibroma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(6 intermediate revisions by 3 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
Dermatofibroma is a common [[benign]] [[skin lesion]] that is seen in almost 3000 dermatophatology [[laboratory]] specimens per 100,000 ones. As most of [[patients]] with Dermatofibroma are [[asymptomatic]], the worldwide [[incidence]] of Dermatofibroma is unknown. [[Patients]] of all age groups may develop Dermatofibroma. Although, it is more occurred in 20s to 40s ages. There is no [[racial]] predilection to dermatofibroma. [[Female]] are more commonly affected by Dermatofibroma than [[male]]. The [[female]] to [[male]] [[ratio]] is approximately 2 to 1.
Dermatofibroma is a common [[benign]] [[skin lesion]] that is seen in almost 3000 dermatophatology [[laboratory]] specimens per 100,000 ones. As most of [[patients]] with dermatofibroma are [[asymptomatic]], the worldwide [[incidence]] of dermatofibroma is unknown. [[Patients]] of all age groups may develop dermatofibroma. Although, it is more occurred in 20s to 40s ages. There is no [[racial]] predilection to dermatofibroma. [[Female]] are more commonly affected by dermatofibroma than [[male]]. The [[female]] to [[male]] [[ratio]] is approximately 2 to 1.


==Epidemiology and Demographics==
==Epidemiology ==
===Prevalence===
===Prevalence===
*Dermatofibroma is a common [[benign]] [[skin lesion]] that is seen in almost 3000 dermatophatology [[laboratory]] specimens per 100,000 ones. <ref name="AgarwalGopinath2017">{{cite journal|last1=Agarwal|first1=Atin|last2=Gopinath|first2=Arun|last3=Tetzlaff|first3=Michael T.|last4=Prieto|first4=Victor G.|title=Phosphohistone-H3 and Ki67|journal=The American Journal of Dermatopathology|volume=39|issue=7|year=2017|pages=504–507|issn=0193-1091|doi=10.1097/DAD.0000000000000690}}</ref><ref name="BuehlerWeisman2017">{{cite journal|last1=Buehler|first1=Darya|last2=Weisman|first2=Paul|title=Soft Tissue Tumors of Uncertain Histogenesis|journal=Clinics in Laboratory Medicine|volume=37|issue=3|year=2017|pages=647–671|issn=02722712|doi=10.1016/j.cll.2017.06.005}}</ref>
*Dermatofibroma is a common [[benign]] [[skin lesion]] that is seen in almost 3000 dermatophatology [[laboratory]] specimens per 100,000 ones. <ref name="AgarwalGopinath2017">{{cite journal|last1=Agarwal|first1=Atin|last2=Gopinath|first2=Arun|last3=Tetzlaff|first3=Michael T.|last4=Prieto|first4=Victor G.|title=Phosphohistone-H3 and Ki67|journal=The American Journal of Dermatopathology|volume=39|issue=7|year=2017|pages=504–507|issn=0193-1091|doi=10.1097/DAD.0000000000000690}}</ref><ref name="BuehlerWeisman2017">{{cite journal|last1=Buehler|first1=Darya|last2=Weisman|first2=Paul|title=Soft Tissue Tumors of Uncertain Histogenesis|journal=Clinics in Laboratory Medicine|volume=37|issue=3|year=2017|pages=647–671|issn=02722712|doi=10.1016/j.cll.2017.06.005}}</ref>


===Incidence===
===Incidence===
*As most of [[patients]] with Dermatofibroma are [[asymptomatic]], the worldwide [[incidence]] of Dermatofibroma is unknown.<ref name="BuehlerWeisman2017">{{cite journal|last1=Buehler|first1=Darya|last2=Weisman|first2=Paul|title=Soft Tissue Tumors of Uncertain Histogenesis|journal=Clinics in Laboratory Medicine|volume=37|issue=3|year=2017|pages=647–671|issn=02722712|doi=10.1016/j.cll.2017.06.005}}</ref><ref name="BandyopadhyayBesra2016">{{cite journal|last1=Bandyopadhyay|first1=MousumiRoy|last2=Besra|first2=Mrinal|last3=Dutta|first3=Somasree|last4=Sarkar|first4=Somnath|title=Dermatofibroma: Atypical presentations|journal=Indian Journal of Dermatology|volume=61|issue=1|year=2016|pages=121|issn=0019-5154|doi=10.4103/0019-5154.174131}}</ref>
*As most of [[patients]] with dermatofibroma are [[asymptomatic]], the worldwide [[incidence]] of dermatofibroma is unknown.<ref name="BuehlerWeisman2017">{{cite journal|last1=Buehler|first1=Darya|last2=Weisman|first2=Paul|title=Soft Tissue Tumors of Uncertain Histogenesis|journal=Clinics in Laboratory Medicine|volume=37|issue=3|year=2017|pages=647–671|issn=02722712|doi=10.1016/j.cll.2017.06.005}}</ref><ref name="BandyopadhyayBesra2016">{{cite journal|last1=Bandyopadhyay|first1=MousumiRoy|last2=Besra|first2=Mrinal|last3=Dutta|first3=Somasree|last4=Sarkar|first4=Somnath|title=Dermatofibroma: Atypical presentations|journal=Indian Journal of Dermatology|volume=61|issue=1|year=2016|pages=121|issn=0019-5154|doi=10.4103/0019-5154.174131}}</ref>
 
== Demographics ==


===Age===
===Age===
*[[Patients]] of all age groups may develop dermatofibroma. Although, it is more common in the 20s to 40s ages. <ref name="AgarwalGopinath2017">{{cite journal|last1=Agarwal|first1=Atin|last2=Gopinath|first2=Arun|last3=Tetzlaff|first3=Michael T.|last4=Prieto|first4=Victor G.|title=Phosphohistone-H3 and Ki67|journal=The American Journal of Dermatopathology|volume=39|issue=7|year=2017|pages=504–507|issn=0193-1091|doi=10.1097/DAD.0000000000000690}}</ref><ref name="BuehlerWeisman2017">{{cite journal|last1=Buehler|first1=Darya|last2=Weisman|first2=Paul|title=Soft Tissue Tumors of Uncertain Histogenesis|journal=Clinics in Laboratory Medicine|volume=37|issue=3|year=2017|pages=647–671|issn=02722712|doi=10.1016/j.cll.2017.06.005}}</ref><ref name="ŞenelYuyucu Karabulut2015">{{cite journal|last1=Şenel|first1=E.|last2=Yuyucu Karabulut|first2=Y.|last3=Doğruer Şenel|first3=S.|title=Clinical, histopathological, dermatoscopic and digital microscopic features of dermatofibroma: a retrospective analysis of 200 lesions|journal=Journal of the European Academy of Dermatology and Venereology|volume=29|issue=10|year=2015|pages=1958–1966|issn=09269959|doi=10.1111/jdv.13092}}</ref><ref name="HanChang2011">{{cite journal|last1=Han|first1=Tae Young|last2=Chang|first2=Hee Sun|last3=Lee|first3=June Hyun Kyung|last4=Lee|first4=Won-Mi|last5=Son|first5=Sook-Ja|title=A Clinical and Histopathological Study of 122 Cases of Dermatofibroma (Benign Fibrous Histiocytoma)|journal=Annals of Dermatology|volume=23|issue=2|year=2011|pages=185|issn=1013-9087|doi=10.5021/ad.2011.23.2.185}}</ref>
*[[Patients]] of all age groups may develop dermatofibroma. Although, it is more common in the 20s to 40s ages. <ref name="AgarwalGopinath2017">{{cite journal|last1=Agarwal|first1=Atin|last2=Gopinath|first2=Arun|last3=Tetzlaff|first3=Michael T.|last4=Prieto|first4=Victor G.|title=Phosphohistone-H3 and Ki67|journal=The American Journal of Dermatopathology|volume=39|issue=7|year=2017|pages=504–507|issn=0193-1091|doi=10.1097/DAD.0000000000000690}}</ref><ref name="BuehlerWeisman2017">{{cite journal|last1=Buehler|first1=Darya|last2=Weisman|first2=Paul|title=Soft Tissue Tumors of Uncertain Histogenesis|journal=Clinics in Laboratory Medicine|volume=37|issue=3|year=2017|pages=647–671|issn=02722712|doi=10.1016/j.cll.2017.06.005}}</ref><ref name="HanChang2011">{{cite journal|last1=Han|first1=Tae Young|last2=Chang|first2=Hee Sun|last3=Lee|first3=June Hyun Kyung|last4=Lee|first4=Won-Mi|last5=Son|first5=Sook-Ja|title=A Clinical and Histopathological Study of 122 Cases of Dermatofibroma (Benign Fibrous Histiocytoma)|journal=Annals of Dermatology|volume=23|issue=2|year=2011|pages=185|issn=1013-9087|doi=10.5021/ad.2011.23.2.185}}</ref>


===Race===
===Race===
Line 21: Line 23:
===Gender===
===Gender===


*[[Female]] are more commonly affected by Dermatofibroma than [[male]]. The [[female]] to [[male]] [[ratio]] is approximately 2 to 1.<ref name="AgarwalGopinath2017">{{cite journal|last1=Agarwal|first1=Atin|last2=Gopinath|first2=Arun|last3=Tetzlaff|first3=Michael T.|last4=Prieto|first4=Victor G.|title=Phosphohistone-H3 and Ki67|journal=The American Journal of Dermatopathology|volume=39|issue=7|year=2017|pages=504–507|issn=0193-1091|doi=10.1097/DAD.0000000000000690}}</ref><ref name="BandyopadhyayBesra2016">{{cite journal|last1=Bandyopadhyay|first1=MousumiRoy|last2=Besra|first2=Mrinal|last3=Dutta|first3=Somasree|last4=Sarkar|first4=Somnath|title=Dermatofibroma: Atypical presentations|journal=Indian Journal of Dermatology|volume=61|issue=1|year=2016|pages=121|issn=0019-5154|doi=10.4103/0019-5154.174131}}</ref><ref name="ŞenelYuyucu Karabulut2015">{{cite journal|last1=Şenel|first1=E.|last2=Yuyucu Karabulut|first2=Y.|last3=Doğruer Şenel|first3=S.|title=Clinical, histopathological, dermatoscopic and digital microscopic features of dermatofibroma: a retrospective analysis of 200 lesions|journal=Journal of the European Academy of Dermatology and Venereology|volume=29|issue=10|year=2015|pages=1958–1966|issn=09269959|doi=10.1111/jdv.13092}}</ref><ref name="HanChang2011">{{cite journal|last1=Han|first1=Tae Young|last2=Chang|first2=Hee Sun|last3=Lee|first3=June Hyun Kyung|last4=Lee|first4=Won-Mi|last5=Son|first5=Sook-Ja|title=A Clinical and Histopathological Study of 122 Cases of Dermatofibroma (Benign Fibrous Histiocytoma)|journal=Annals of Dermatology|volume=23|issue=2|year=2011|pages=185|issn=1013-9087|doi=10.5021/ad.2011.23.2.185}}
*[[Female]] are more commonly affected by dermatofibroma than [[male]]. The [[female]] to [[male]] [[ratio]] is approximately 2 to 1.<ref name="AgarwalGopinath2017">{{cite journal|last1=Agarwal|first1=Atin|last2=Gopinath|first2=Arun|last3=Tetzlaff|first3=Michael T.|last4=Prieto|first4=Victor G.|title=Phosphohistone-H3 and Ki67|journal=The American Journal of Dermatopathology|volume=39|issue=7|year=2017|pages=504–507|issn=0193-1091|doi=10.1097/DAD.0000000000000690}}</ref><ref name="BandyopadhyayBesra2016">{{cite journal|last1=Bandyopadhyay|first1=MousumiRoy|last2=Besra|first2=Mrinal|last3=Dutta|first3=Somasree|last4=Sarkar|first4=Somnath|title=Dermatofibroma: Atypical presentations|journal=Indian Journal of Dermatology|volume=61|issue=1|year=2016|pages=121|issn=0019-5154|doi=10.4103/0019-5154.174131}}</ref><ref name="ŞenelYuyucu Karabulut2015">{{cite journal|last1=Şenel|first1=E.|last2=Yuyucu Karabulut|first2=Y.|last3=Doğruer Şenel|first3=S.|title=Clinical, histopathological, dermatoscopic and digital microscopic features of dermatofibroma: a retrospective analysis of 200 lesions|journal=Journal of the European Academy of Dermatology and Venereology|volume=29|issue=10|year=2015|pages=1958–1966|issn=09269959|doi=10.1111/jdv.13092}}</ref><ref name="HanChang2011">{{cite journal|last1=Han|first1=Tae Young|last2=Chang|first2=Hee Sun|last3=Lee|first3=June Hyun Kyung|last4=Lee|first4=Won-Mi|last5=Son|first5=Sook-Ja|title=A Clinical and Histopathological Study of 122 Cases of Dermatofibroma (Benign Fibrous Histiocytoma)|journal=Annals of Dermatology|volume=23|issue=2|year=2011|pages=185|issn=1013-9087|doi=10.5021/ad.2011.23.2.185}}</ref>
===Region===
*The majority of [disease name] cases are reported in [geographical region].
 
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].


==References==
==References==
Line 29: Line 35:
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Up-To-Date]]
[[Category:Up-To-Date]]
[[Category:Primary care]]
[[Category:Dermatology]]
[[Category:Dermatology]]

Latest revision as of 21:17, 29 July 2020

Dermatofibroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Dermatofibroma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Dermatofibroma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Dermatofibroma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Dermatofibroma epidemiology and demographics

CDC on Dermatofibroma epidemiology and demographics

Dermatofibroma epidemiology and demographics in the news

Blogs on Dermatofibroma epidemiology and demographics

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Dermatofibroma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]

Overview

Dermatofibroma is a common benign skin lesion that is seen in almost 3000 dermatophatology laboratory specimens per 100,000 ones. As most of patients with dermatofibroma are asymptomatic, the worldwide incidence of dermatofibroma is unknown. Patients of all age groups may develop dermatofibroma. Although, it is more occurred in 20s to 40s ages. There is no racial predilection to dermatofibroma. Female are more commonly affected by dermatofibroma than male. The female to male ratio is approximately 2 to 1.

Epidemiology

Prevalence

Incidence

Demographics

Age

  • Patients of all age groups may develop dermatofibroma. Although, it is more common in the 20s to 40s ages. [1][2][4]

Race

Gender

Region

  • The majority of [disease name] cases are reported in [geographical region].
  • [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

References

  1. 1.0 1.1 1.2 1.3 Agarwal, Atin; Gopinath, Arun; Tetzlaff, Michael T.; Prieto, Victor G. (2017). "Phosphohistone-H3 and Ki67". The American Journal of Dermatopathology. 39 (7): 504–507. doi:10.1097/DAD.0000000000000690. ISSN 0193-1091.
  2. 2.0 2.1 2.2 Buehler, Darya; Weisman, Paul (2017). "Soft Tissue Tumors of Uncertain Histogenesis". Clinics in Laboratory Medicine. 37 (3): 647–671. doi:10.1016/j.cll.2017.06.005. ISSN 0272-2712.
  3. 3.0 3.1 3.2 Bandyopadhyay, MousumiRoy; Besra, Mrinal; Dutta, Somasree; Sarkar, Somnath (2016). "Dermatofibroma: Atypical presentations". Indian Journal of Dermatology. 61 (1): 121. doi:10.4103/0019-5154.174131. ISSN 0019-5154.
  4. 4.0 4.1 Han, Tae Young; Chang, Hee Sun; Lee, June Hyun Kyung; Lee, Won-Mi; Son, Sook-Ja (2011). "A Clinical and Histopathological Study of 122 Cases of Dermatofibroma (Benign Fibrous Histiocytoma)". Annals of Dermatology. 23 (2): 185. doi:10.5021/ad.2011.23.2.185. ISSN 1013-9087.
  5. Şenel, E.; Yuyucu Karabulut, Y.; Doğruer Şenel, S. (2015). "Clinical, histopathological, dermatoscopic and digital microscopic features of dermatofibroma: a retrospective analysis of 200 lesions". Journal of the European Academy of Dermatology and Venereology. 29 (10): 1958–1966. doi:10.1111/jdv.13092. ISSN 0926-9959.